日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Triple-negative breast cancer modifies the systemic immune landscape and alters neutrophil functionality

三阴性乳腺癌改变全身免疫状况并改变中性粒细胞的功能

Noor A M Bakker, Hannah Garner #, Ewald van Dyk #, Elisa Champanhet, Chris Klaver, Maxime Duijst, Leonie Voorwerk, Iris Nederlof, Rosie Voorthuis, Marte C Liefaard, Marja Nieuwland, Iris de Rink, Onno B Bleijerveld, Hendrika M Oosterkamp, Lodewyk F A Wessels, Marleen Kok, Karin E de Visser4

A comparative study of four cell-free DNA assays for detecting circulating tumor DNA in early breast cancer

四种无细胞DNA检测方法在早期乳腺癌循环肿瘤DNA检测中的比较研究

Mulder, Charlotta V; Jongbloed, Elisabeth M; Liefaard, Marte C; Makrodimitris, Stavros; Hazelaar, Daan M; Beaufort, Corine M; de Weerd, Vanja; Mulder, Lennart; van Deurzen, Carolien H M; Sonke, Gabe S; Jager, Agnes; Wilting, Saskia M; Martens, John W M; Jansen, Maurice P H M; Lips, Esther H

The effectiveness of the Dutch juvenile diversion program Halt: study protocol for a randomized controlled trial

荷兰青少年分流计划 Halt 的有效性:一项随机对照试验的研究方案

van Delft, Benthe J; Zeijlmans, Kirti; Asscher, Jessica J; Liefaard, Ton; van der Laan, André M

Comprehensive analysis of the systemic immune landscape across breast cancer subtypes and disease stages

对乳腺癌亚型和疾病阶段的系统性免疫图谱进行全面分析

Bakker, N A M; Garner, H; Geurts, V C M; Champanhet, E; Klaver, C; Duijst, M; Nederlof, I; Gielen, R C A M; de Graaf, M; Voorthuis, R; Liefaard, M C; Lips, E H; Oosterkamp, H M; Kok, M; de Visser, K E

Tumor-infiltrating lymphocytes in HER2-positive breast cancer treated with neoadjuvant chemotherapy and dual HER2-blockade

接受新辅助化疗和双重 HER2 阻断治疗的 HER2 阳性乳腺癌中的肿瘤浸润淋巴细胞

Liefaard, M C; van der Voort, A; van Seijen, M; Thijssen, B; Sanders, J; Vonk, S; Mittempergher, L; Bhaskaran, R; de Munck, L; van Leeuwen-Stok, A E; Salgado, R; Horlings, H M; Lips, E H; Sonke, G S

Predicting treatment outcome using kinome activity profiling in HER2+ breast cancer biopsies

使用 HER2+ 乳腺癌活检中的激酶组活性分析预测治疗结果

Donna O Debets, Erik L de Graaf, Marte C Liefaard, Gabe S Sonke, Esther H Lips, Anna Ressa, Maarten Altelaar

Extrapolation of the Efficacy and Pharmacokinetics of Belimumab to Support its Use in Children with Lupus Nephritis

贝利木单抗疗效和药代动力学的外推以支持其在儿童狼疮性肾炎中的应用

Dimelow, Richard; Liefaard, Lia; Green, Yulia; Tomlinson, Ryan

Deep (phospho)proteomics profiling of pre- treatment needle biopsies identifies signatures of treatment resistance in HER2+ breast cancer

治疗前针吸活检的深度(磷酸化)蛋白质组学分析可识别 HER2+ 乳腺癌的治疗耐药特征

Donna O Debets, Kelly E Stecker, Anastasia Piskopou, Marte C Liefaard, Jelle Wesseling, Gabe S Sonke, Esther H Lips, Maarten Altelaar

Tumour-educated platelets for breast cancer detection: biological and technical insights

用于乳腺癌检测的肿瘤教育血小板:生物学和技术见解

Marte C Liefaard, Kat S Moore, Lennart Mulder, Daan van den Broek, Jelle Wesseling, Gabe S Sonke, Lodewyk F A Wessels, Matti Rookus, Esther H Lips

BluePrint molecular subtypes predict response to neoadjuvant pertuzumab in HER2-positive breast cancer

BluePrint分子亚型可预测HER2阳性乳腺癌对新辅助帕妥珠单抗的反应

Liefaard, M C; van der Voort, A; van Ramshorst, M S; Sanders, J; Vonk, S; Horlings, H M; Siesling, S; de Munck, L; van Leeuwen, A E; Kleijn, M; Mittempergher, L; Kuilman, M M; Glas, A M; Wesseling, J; Lips, E H; Sonke, G S